Showing results (11-20 of 255) with videos related to
Sort By:
Pageof 26
Therapeutic Drug Monitoring|December 1, 1992
A within-subject analysis of carbamazepine disposition related to development in children with epilepsyF Albani, R Riva, M Contin, et al.Clinical Pharmacokinetics|December 1, 1996
Pharmacokinetic interactions between antiepileptic drugs. Clinical considerationsR Riva, F Albani, M Contin, et al.Clinical Pharmacokinetics|June 1, 1996
Pharmacokinetic optimisation in the treatment of Parkinson's diseaseM Contin, R Riva, F Albani, et al.British Journal of Clinical Pharmacology|August 1, 1984
Stereoselective binding of propranolol enantiomers to human alpha 1-acid glycoprotein and human plasmaF Albani, R Riva, M Contin, et al.Journal of Chromatography. B, Biomedical Sciences and Applications|October 5, 2001
Simple and rapid liquid chromatographic-turbo ion spray mass spectrometric determination of topiramate in human plasmaM Contin, R Riva, F Albani, et al.Therapeutic Drug Monitoring|December 22, 1999
Effect of felbamate on clobazam and its metabolite kinetics in patients with epilepsyM Contin, R Riva, F Albani, et al.Clinical Neuropharmacology|October 23, 1997
Relationship between levodopa concentration, dyskinesias, and motor effect in parkinsonian patients: a 3-year follow-up studyM Contin, R Riva, P Martinelli, et al.European Journal of Clinical Pharmacology|January 1, 1986
Altered serum protein binding of carbamazepine in disease states associated with an increased alpha 1-acid glycoprotein concentrationA Baruzzi, M Contin, E Perucca, et al.International Journal of Clinical Pharmacology, Therapy, and Toxicology|May 1, 1985
Propranolol plasma binding and serum lipids during chronic therapy in migraine patientsF Albani, R Riva, P Cortelli, et al.Epilepsia|January 1, 1993
Carnitine disposition before and during valproate therapy in patients with epilepsyR Riva, F Albani, G Gobbi, et al.Pageof 26